Paper32984792
Artificial intelligence in COVID-19 drug repurposing.
Zhou Y and 4 others. Lancet Digit Health, 2020. Cited by 308 papers, by iCite.
Cite this record
ConductScience Library. Artificial intelligence in COVID-19 drug repurposing. Papers, record 32984792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32984792
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Artificial Intelligence | Major topic |
| Drug Repositioning | Major topic |
| COVID-19 Drug Treatment | Major topic |
| Algorithms | |
| Antiviral Agents | |
| Drug Discovery | |
| Drug Therapy, Combination | |
| Humans | |
| SARS-CoV-2 | |
| Treatment Outcome |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| HHSN261200800001C | CCR NIH HHS | United States | PubMed | PubMed | |
| HHSN261200800001E | NCI NIH HHS | United States | PubMed | PubMed | |
| R00 HL138272 | NHLBI NIH HHS | United States | R00HL138272 | PubMed and NIH | NIH RePORTER |
| R01 AG066707 | NIA NIH HHS | United States | R01AG066707 | PubMed and NIH | NIH RePORTER |
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24841273 | Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. | Antimicrob Agents Chemother | 2014 | https://conductscience.org/library/papers/24841273 | PubMed |
| 2 | 30867426 | Network-based prediction of drug combinations. | Nat Commun | 2019 | https://conductscience.org/library/papers/30867426 | PubMed |
| 3 | 32362314 | A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells. | Mol Cell | 2020 | https://conductscience.org/library/papers/32362314 | PubMed |
| 4 | 17687303 | New uses for old drugs. | Nature | 2007 | https://conductscience.org/library/papers/17687303 | PubMed |
| 5 | 32194981 | Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. | Cell Discov | 2020 | https://conductscience.org/library/papers/32194981 | PubMed |
| 6 | 32392282 | Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State. | JAMA | 2020 | https://conductscience.org/library/papers/32392282 | PubMed |
| 7 | 26262116 | Observational Health Data Sciences and Informatics (OHDSI): Opportunities for Observational Researchers. | Stud Health Technol Inform | 2015 | https://conductscience.org/library/papers/26262116 | PubMed |
| 8 | 32393527 | Ethics and governance for digital disease surveillance. | Science | 2020 | https://conductscience.org/library/papers/32393527 | PubMed |
| 9 | 32366720 | Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/32366720 | PubMed |
| 10 | 32558485 | Genomewide Association Study of Severe Covid-19 with Respiratory Failure. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32558485 | PubMed |
| 11 | 32356628 | Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32356628 | PubMed |
| 12 | 30002366 | Network-based approach to prediction and population-based validation of in silico drug repurposing. | Nat Commun | 2018 | https://conductscience.org/library/papers/30002366 | PubMed |
| 13 | 26017442 | Deep learning. | Nature | 2015 | https://conductscience.org/library/papers/26017442 | PubMed |
| 14 | 29849160 | How artificial intelligence is changing drug discovery. | Nature | 2018 | https://conductscience.org/library/papers/29849160 | PubMed |
| 15 | 30921324 | Review: Precision medicine and driver mutations: Computational methods, functional assays and conformational principles for interpreting cancer drivers. | PLoS Comput Biol | 2019 | https://conductscience.org/library/papers/30921324 | PubMed |
| 16 | 29086168 | Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set. | J Cheminform | 2017 | https://conductscience.org/library/papers/29086168 | PubMed |
| 17 | 29906441 | Visible Machine Learning for Biomedicine. | Cell | 2018 | https://conductscience.org/library/papers/29906441 | PubMed |
| 18 | 32649078 | Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32649078 | PubMed |
| 19 | 32032529 | Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. | Lancet | 2020 | https://conductscience.org/library/papers/32032529 | PubMed |
| 20 | 17951106 | Definition, structure, content, use and impacts of electronic health records: a review of the research literature. | Int J Med Inform | 2008 | https://conductscience.org/library/papers/17951106 | PubMed |
Cited by227
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 308 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42773187 | Niclosamide suppresses breast cancer progression and enhances paclitaxel sensitivity by targeting the ATP6AP1-YY1-XIAP axis. | Acta Pharmacol Sin | 2026 | https://conductscience.org/library/papers/42773187 | PubMed |
| 42737761 | Integrating Artificial Intelligence with Emerging Pharmaceutical Technologies: Current Progress, Clinical Translation, and Future Challenges. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737761 | PubMed |
| 42647509 | Systems pharmacology reveals type I interferon and myeloid-like B cell reprogramming as candidate druggable axes in antiphospholipid syndrome. | PLoS One | 2026 | https://conductscience.org/library/papers/42647509 | PubMed |
| 42459675 | Recent applications of artificial intelligence in cancer radiotherapy and immunotherapy: current status and future directions. | Front Immunol | 2026 | https://conductscience.org/library/papers/42459675 | PubMed |
| 42375346 | Opening the black box: insights into ubiquitin-mediated control of innate antiviral immunity and AI-enhanced therapeutics. | Front Immunol | 2026 | https://conductscience.org/library/papers/42375346 | PubMed |
| 42296331 | DrugDL: dual-modal deep learning framework for multi-property drug prediction and targeted therapy discovery. | Bioinformatics | 2026 | https://conductscience.org/library/papers/42296331 | PubMed |
| 42180332 | A phenotype-to-mechanism framework links phenome-wide comorbidity architecture to molecular mechanisms and therapeutic discovery in complex diseases. | medRxiv | 2026 | https://conductscience.org/library/papers/42180332 | PubMed |
| 42124589 | CellAwareGNN: Single-Cell Enhanced Knowledge Graph Foundation Model for Drug Indication Prediction. | bioRxiv | 2026 | https://conductscience.org/library/papers/42124589 | PubMed |
| 42027758 | Artificial intelligence at the frontlines: Emerging infectious and parasitic diseases in the digital era. | New Microbes New Infect | 2026 | https://conductscience.org/library/papers/42027758 | PubMed |
| 41978380 | Artificial intelligence drives the identification and screening of novel antibiotics and antimicrobial peptides. | Brief Bioinform | 2026 | https://conductscience.org/library/papers/41978380 | PubMed |
| 41913792 | Circulating and Respiratory Biomarkers in Sepsis-Induced ARDS: Diagnostic and Prognostic Insights - A Narrative Review. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/41913792 | PubMed |
| 41786310 | Artificial Intelligence in Drug Discovery and Development: Raising Quality per Decision. | Pharmacopsychiatry | 2026 | https://conductscience.org/library/papers/41786310 | PubMed |
| 41685169 | Applications of AI/ML in accelerating the development of pulmonary drug delivery system. | Acta Pharm Sin B | 2026 | https://conductscience.org/library/papers/41685169 | PubMed |
| 41614075 | Xuebijing injection in the treatment of COVID-19: An update on clinical studies, potentially active metabolites and mechanisms. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41614075 | PubMed |
| 41592930 | Artificial Intelligence to Guide Repurposing of Drugs. | Annu Rev Med | 2026 | https://conductscience.org/library/papers/41592930 | PubMed |
| 41568331 | DDA-bench: a manually curated database for benchmarking datasets and baseline performance values in predicting drug-disease associations. | Front Genet | 2025 | https://conductscience.org/library/papers/41568331 | PubMed |
| 41516175 | Biologically Informed Machine Learning Prioritizes Dietary Supplements That Protect Neural Crest Cells from Ethanol-Induced Epigenetic Dysregulation and Developmental Impairment. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41516175 | PubMed |
| 41403729 | The Pharmaceutical Industry's Future: How Artificial Intelligence is Transforming Medicine. | Adv Pharm Bull | 2025 | https://conductscience.org/library/papers/41403729 | PubMed |
| 41373598 | Deep Generative AI for Multi-Target Therapeutic Design: Toward Self-Improving Drug Discovery Framework. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41373598 | PubMed |
| 41306069 | A New Era of Artificial Intelligence (AI): Transforming Drug Discovery and Development. | J Med Chem | 2025 | https://conductscience.org/library/papers/41306069 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AAK1 | 22848 | PubTator's text mining | https://conductscience.org/library/genes/22848 | NCBI Gene |
| ACE2 | 59272 | PubTator's text mining | https://conductscience.org/library/genes/59272 | NCBI Gene |
| FURIN | 5045 | PubTator's text mining | https://conductscience.org/library/genes/5045 | NCBI Gene |
| MTNR1A | 4543 | PubTator's text mining | https://conductscience.org/library/genes/4543 | NCBI Gene |
| NR3C1 | 2908 | PubTator's text mining | https://conductscience.org/library/genes/2908 | NCBI Gene |
| NRP1 | 8829 | PubTator's text mining | https://conductscience.org/library/genes/8829 | NCBI Gene |
| PARP1 | 142 | PubTator's text mining | https://conductscience.org/library/genes/142 | NCBI Gene |
| TMPRSS2 | 7113 | PubTator's text mining | https://conductscience.org/library/genes/7113 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32984792
GET https://conductscience.org/api/papers/v1/32984792/references?page=2